Summary
- Current Price
- As of today, CTXR price is $0.77, up +6.25% on
- Current Price All-Time High
- CTXR price is currently -99.92% below its historical high of $937.50 set on an earlier date
- Market Cap
- CTXR current market cap is $21M, up +13.35% over the past 365 days
- Revenue
- CTXR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CTXR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Citius Pharmaceuticals, Inc. |
| Ticker | NASDAQ: CTXR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | citiuspharma.com |
| Employees | 23 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $0.77 | ||
| Price, 1D Change | +6.25% | |
| $21M | ||
| - | ||
| - | ||
| 2.57 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.38 | ||
| EPS, 1Y Change | +43.37% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.38 | ||
| EPS Estimate | -$1.87 | N/A |
| EPS Est. Change | +44.72% | N/A |
| $0.00 | ||
| Revenue Estimate | $20.84M | N/A |
| Revenue Est. Change | - | N/A |
| $0.77 | ||
| Price Target | $4.00 | - |
| Price Tgt. Change | +422.88% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.63 | -$5.97 | -6.20% | |
| -$2.08 | -$3.38 | -62.64% | |
| -$1.87 | N/A | +44.72% | |
| -$0.81 | N/A | +76.06% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $20.84M | N/A | - | |
| $52.58M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -40.23% | ||
| -96.79% | ||
| +13.35% | ||
| -86.11% | ||
| 0.00% | ||
| 0.00% | ||
| +43.37% | ||
| +41.24% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $0.77 | ||
| $0.82 | ||
| $0.58 | ||
| $1.00 | ||
| $0.61 | ||
| $0.04 | ||
| 2.57 | ||
| $0.07 | ||
| 63.47 | ||
| 184.00% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$3.38 | ||
| -$214.20K | ||
| - | ||
| -$38.53M | ||
| - | ||
| -$39.74M | ||
| - | ||
| -$38.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.03 | ||
| 0.62 | ||
| 0.13 | ||
| - | ||
| - | ||
| -3.44 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 3.74 | ||
| 0.34 | ||
| -0.31 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $67.55M | ||
| $4.25M | ||
| $131.16M | ||
| $27.93M | ||
| $53.63M | ||
| $44.91M | ||
| $1.81M | ||
| $1.09M | ||
| $13.69M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $37.43M | ||
| $38.31M | ||
| $214.20K | ||
| $0.00 | ||
| $214.20K | ||
| $0.00 | ||
| $1.06M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$26.55M | ||
| -$5.75M | ||
| $33.30M | ||
| $5.75M | ||
| -$32.30M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| Maxim Group | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CTXR
FAQ
- What is the ticker symbol for Citius Pharmaceuticals, Inc.?
- The ticker symbol for Citius Pharmaceuticals, Inc. is NASDAQ:CTXR
- Does Citius Pharmaceuticals, Inc. pay dividends?
- No, Citius Pharmaceuticals, Inc. does not pay dividends
- What sector is Citius Pharmaceuticals, Inc. in?
- Citius Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Citius Pharmaceuticals, Inc. in?
- Citius Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Citius Pharmaceuticals, Inc. based in?
- Citius Pharmaceuticals, Inc. is headquartered in United States
- When did Citius Pharmaceuticals, Inc. go public?
- Citius Pharmaceuticals, Inc. initial public offering (IPO) was on October 2, 2014
- Is Citius Pharmaceuticals, Inc. in the S&P 500?
- No, Citius Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Citius Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Citius Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Citius Pharmaceuticals, Inc. in the Dow Jones?
- No, Citius Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Citius Pharmaceuticals, Inc. last earnings report?
- Citius Pharmaceuticals, Inc.'s most recent earnings report was on May 15, 2026
- When does Citius Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Citius Pharmaceuticals, Inc. is August 14, 2026
Data Sources & References
- CTXR Official Website citiuspharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1506251/000121390025125333/0001213900-25-125333-index.htm
- CTXR Profile on Yahoo Finance finance.yahoo.com/quote/CTXR
- CTXR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ctxr